Search

Your search keyword '"Paxton WA"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Paxton WA" Remove constraint Author: "Paxton WA"
101 results on '"Paxton WA"'

Search Results

1. Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients

2. Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission

3. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study : a prospective, multicentre cohort study

4. A prenylated dsRNA sensor protects against severe COVID-19

5. Mapping the human genetic architecture of COVID-19

6. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

8. Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.

11. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

12. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

13. Development of a pseudo-typed virus particle based method to determine the efficacy of virucidal agents.

14. The ecology of viruses in urban rodents with a focus on SARS-CoV-2.

15. Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.

16. Glycan dependent phenotype differences of HIV-1 generated from macrophage versus CD4 + T helper cell populations.

17. SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.

18. A Quantitative Method for the Study of HIV-1 and Mycobacterium tuberculosis Coinfection.

19. Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: Antibody dynamics and linkage to severity of COVID-19 in hospital inpatients.

20. The HCV Envelope Glycoprotein Down-Modulates NF-κB Signalling and Associates With Stimulation of the Host Endoplasmic Reticulum Stress Pathway.

21. Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Alu Repeat Sequences.

22. Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection.

23. Generation of Liposomes to Study the Effect of Mycobacterium Tuberculosis Lipids on HIV-1 cis - and trans -Infections.

24. Ebola virus antibody decay-stimulation in a high proportion of survivors.

25. Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease.

26. Measuring the Success of HIV-1 Cure Strategies.

27. Bile-salt stimulated lipase polymorphisms do not associate with HCV susceptibility.

28. Schistosoma mansoni soluble egg antigen (SEA) and recombinant Omega-1 modulate induced CD4+ T-lymphocyte responses and HIV-1 infection in vitro.

29. SNP rs688 within the low-density lipoprotein receptor (LDL-R) gene associates with HCV susceptibility.

30. Comparative analysis and generation of a robust HIV-1 DNA quantification assay.

31. Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.

32. Blood CXCR3 + CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals.

33. DC-SIGN Polymorphisms Associate with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.

35. Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4+ Th-Cells.

36. Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the Antibody.

37. Association between gp120 envelope V1V2 and V4V5 variable loop profiles in a defined HIV-1 transmission cluster.

38. Colorectal mucus binds DC-SIGN and inhibits HIV-1 trans-infection of CD4+ T-lymphocytes.

39. Improved metastasis-free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations.

40. The search for a T cell line for testing novel antiviral strategies against HIV-1 isolates of diverse receptor tropism and subtype origin.

41. Increased HIV-1 activity in anal high-grade squamous intraepithelial lesions compared with unaffected anal mucosa in men who have sex with men.

42. HIV-1 autologous antibody neutralization associates with mother to child transmission.

43. Quantitation of HIV-1 DNA with a sensitive TaqMan assay that has broad subtype specificity.

44. Human immunodeficiency virus type 1 gp120 envelope characteristics associated with disease progression differ in family members infected with genetically similar viruses.

45. Use of (alternative) coreceptors for HIV entry.

46. HIV type 1 mother-to-child transmission facilitated by distinctive glycosylation sites in the gp120 envelope glycoprotein.

47. Effects of helminths and Mycobacterium tuberculosis infection on HIV-1: a cellular immunological perspective.

48. Transmission of two distinct HIV type 1 strains to an individual that were harbored for many years by another.

49. HIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism.

50. Innate immune factors associated with HIV-1 transmission.

Catalog

Books, media, physical & digital resources